Ropes & Gray advised precision medicines company MOMA Therapeutics in a strategic collaboration and licensing agreement with Swiss pharmaceutical leader Roche that will provide Roche with access to MOMA’s KnowledgeBase platform for the identification of a certain number of novel drug targets involved in promoting cancer cell growth and survival. The transaction was announced on January 4.
Under the agreement, Cambridge, Massachusetts-based MOMA will receive a $66 million upfront cash payment and is also eligible for discovery, development and commercialization milestone payments exceeding $2 billion, along with tiered royalties.
The Ropes & Gray team was led by life sciences licensing partner Hannah England and life sciences licensing associate Ian Nilsen.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.